Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 8260367

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
1993 Dec
First author
Bleehen NM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Bleehen NM
      type
      Author
    2. name
      Girling DJ
      type
      Author
    3. name
      Machin D
      type
      Author
    4. name
      Stephens RJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Bleehen NM
      type
      Author
    2. name
      Girling DJ
      type
      Author
    3. name
      Machin D
      type
      Author
    4. name
      Stephens RJ
      type
      Author
    bibliography ids
    1. nci-bib-d66574e9b0460eff6329ad5c
    book metadata
    content sha256
    14c963ba52c6ea4e40574dabd01c52482014f2aef4779bb7d3738e21e8208236
    document type
    citation
    dois
    1. 10.1038/bjc.1993.496
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:8260367
    immutable id
    pubmed:8260367@14c963ba52c6ea4e40574dabd01c52482014f2aef4779bb7d3738e21e8208236
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    6
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    1150-6
    volume
    68
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      8260367
      provenance
      batch id
      83ec39f94a925b232876
      provider
      NCBI PubMed ESummary
      record sha256
      dc47f0cb6ac15dd6a20c125cea8744049717f6d2db5eb24f72bc188c4b6227b4
      response sha256
      9cea37bf3451de6aa8c54c490de635080a496054249095b8c254be0e69164eca
      retrieved at
      2026-09-09T23:45:20.996485+00:00
      publication date
      display
      1993 Dec
      precision
      month
      year
      1993
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Journal Article
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/8260367/
      title
      A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.

      Preserved source evidence · Not medical advice